Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Research and Manufacturers of America (PhRMA) website: www.phrma.org
PhRMA "represents the leading research-based pharmaceutical and biotechnology companies in the United States".
As of November 2004 its members include:
3M, Abbott Laboratories, Amgen, AstraZeneca, Aventis, Bayer, Berlex (part of Schering AG), Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Pharmaceutical, Eli Lilly, Fujisawa Healthcare, GE Healthcare (part of General Electric), Genzyme, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Procter & Gamble, Novartis, Organon, Otsuka, Pfizer, Purdue Pharma, Sanofi-Aventis, Savient, Schering-Plough, Schwarz Pharma, Sepracor, Serono, Solvay, Valeant, Wyeth
Its affiliates and associates include:
aaiPharma, Accenture, Alkermes, Altana Pharma, Amylin, Automsoft, Boston Consulting Group, Celgene, Cephalon, CommonHealth, Compugen, Corus Pharma, Dendrite International, Eisai, Enzon, Ernst & Young, Euro RSCG Life, Eyetech Pharmaceuticals, FCB Healthcare, HealthSTAR Communications, ICOS, Idenix, IMS Health, Isis Pharmaceuticals, J. Scott International, KPMG, Maxim Pharmaceuticals, McGraw-Hill, McKesson, Medi-Promotions, Medicus Group, MediMedia, MGI Pharma, Nelson Communications, NOP World Health, Novo Nordisk, PDI, Penwest Pharmaceuticals, Quintiles Transnational, Saatchi, Sankyo Pharma, Sigma-Tau Pharmaceuticals, Stressgen Biotechnologies, Takeda Pharmaceuticals, TargetRx, Theravance, Thomson Healthcare, Vela Pharmaceuticals, Ventiv Health, Yamanouchi Pharma
PhRMA's current full list of members.
Related stories and components
Author: CBS 60 Minutes (USA)
"The Cost of Cancer Drugs", 5 Oct 2014...
Author: Sebastian Krueger, Open Society Foundations
Patent protections allow for inflated monopoly pricing and keep generic drugs, which are cheaper, from going to market. Secret international trade deals impose the pharmaceutical companies’ high prices on foreign nations...But Fire in the Blood asks us...
- Related in-depth areas: Feature-length documentaries, films & trailers
Author: David Brown, Washington Post
Behind...talks at the United Nations and a...document about the need to fight noncommunicable diseases...is a fierce struggle between commercial and health interests...Some of the issues...are the same ones at the heart of...the battle against smoking...
Author: Global Health Progress Initiative
Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today... The United...
Author: United Nations Economic and Social Council (ECOSOC)
- Related stories: UN event brings together NGOs & pharmaceutical companies on initiatives to improve health in poor countries
- Related in-depth areas: Short videos & news items
Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na...
Author: Keya Acharya, Inter Press Service
Under the drug regulatory process any drug, whether patented or not, must pass safety, efficacy and quality tests for marketing from the Drug Controller-General of India (DGCI)...the DGCI can [currently] rely on previous test data to approve subsequent...
Author: John Carreyrou, The Wall Street Journal [USA]
In the fall of 2003, Abbott Laboratories...seized on an unusual weapon that helped [its AIDS drug] Kaletra's global sales top $1 billion a year, even as it exposed Abbott to criticism that it was endangering patients. The weapon was an older Abbott...
- Related companies: Abbott Laboratories
Author: Alex Berenson, New York Times
When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines...Eli Lilly and some other companies...